About Foamix


About Foamix

Foamix is a specialty pharmaceutical company focused on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological conditions.

Through our proprietary technology platform, Foamix has developed a line of unique and innovative topical foam formulations. This platform provides the versatility to develop new topical products for the possible treatment of dermatological and other conditions. The potential advantages of foam include enhanced usability and compliance, improved tolerability, and targeted drug delivery. Foamix has developed and patented several unique classes of foam formulations, including those illustrated below.

about foamix
 

Our company has two lead investigational new drug candidates in advanced clinical stages:

  • FMX101, minocycline foam for the potential treatment of moderate-to-severe acne.
  • FMX103, minocycline foam for the potential treatment of moderate-to-severe papulopustular rosacea.